Provided By PR Newswire
Last update: Aug 6, 2024
Conference call to be held on Tuesday, August 20, 2024, at 10:00 a.m. U.S. EDT
REHOVOT, Israel, Aug. 6, 2024 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced that it will report financial statements for the second quarter of 2024 on Tuesday, August 20, 2024, before the opening of the U.S. financial markets. The Company will then host a conference call and webcast to discuss its financial statements and corporate updates on August 20 at 10:00 a.m. Eastern Daylight Time.
Read more at prnewswire.comNASDAQ:CLGN (2/21/2025, 8:09:58 PM)
3.47
-0.01 (-0.22%)
Find more stocks in the Stock Screener